tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Changmao Biochemical Announces Delay in Circular Dispatch for Major Transaction

Story Highlights
Changmao Biochemical Announces Delay in Circular Dispatch for Major Transaction

Meet Your ETF AI Analyst

Changmao Biochemical Engineering Co. Ltd. Class H ( (HK:0954) ) has shared an update.

Changmao Biochemical Engineering Co. Ltd. announced a delay in the dispatch of a circular related to a major transaction involving a sale and leaseback arrangement. The company has received a waiver from the Stock Exchange for this delay, with a new deadline set for August 12, 2025, to dispatch the circular.

More about Changmao Biochemical Engineering Co. Ltd. Class H

Changmao Biochemical Engineering Co. Ltd. is a joint stock limited company incorporated in the People’s Republic of China. It operates in the biochemical engineering industry, focusing on the production and sale of biochemical products.

Average Trading Volume: 401,920

Technical Sentiment Signal: Sell

Current Market Cap: HK$164.2M

See more insights into 0954 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1